Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alveolar bone osteoblast differentiation and Runx2/Cbfa1 expression.

Hiran Perinpanayagam1, Thomas Martin, Vartika Mithal

  • 1School of Dental Medicine, University at Buffalo, 135 Foster Hall, Buffalo, NY 14214-8031, USA. hp7@buffalo.edu

Archives of Oral Biology
|October 29, 2005
PubMed
Summary

Runx2/Cbfa1 transcription factor expression increases rapidly in human alveolar bone cells, indicating their osteogenic potential. This study characterizes this key factor in human osteoblast differentiation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tooth Function of the Northern Raccoon (Procyon lotor) and Adaptations to Omnivory in the Order Carnivora.

Journal of morphology·2026
Same author

Plain language summary of publication of how long people with relapsed multiple myeloma lived after treatment in the IKEMA study: Isatuximab plus carfilzomib and dexamethasone versus carfilzomib and dexamethasone.

Future oncology (London, England)·2026
Same author

Development of a Fully Non-Viral 1XX-enhanced BCMA CAR-T Cell Therapy for Multiple Myeloma.

bioRxiv : the preprint server for biology·2026
Same author

Antibiotic-associated dysbiosis and bispecific antibody outcomes in multiple myeloma.

Journal for immunotherapy of cancer·2026
Same author

Isatuximab, bortezomib, lenalidomide, and dexamethasone for multiple myeloma: dynamics of MRD negativity in the IMROZ study.

Blood·2026
Same author

Feasibility of decentralized real-world monitoring of SARS-CoV-2 booster vaccines and COVID-19 outcomes in myeloma.

Blood advances·2026

Area of Science:

  • Oral biology and regenerative medicine
  • Cellular and molecular biology
  • Biochemistry and biophysics

Background:

  • Alveolar bone cells share similarities with skeletal osteoblasts but have unique characteristics.
  • Osteoblast differentiation is governed by the Runx2/Cbfa1 transcription factor.
  • Existing research on Runx2/Cbfa1 in human osteoblasts presents conflicting results.

Purpose of the Study:

  • To investigate and characterize Runx2/Cbfa1 expression in primary human alveolar bone cell cultures.
  • To understand the role of Runx2/Cbfa1 in osteoblastic differentiation of human alveolar bone cells.

Main Methods:

  • Primary human alveolar bone cells were cultured using explant methods.
  • Osteogenic differentiation was induced using ascorbate, beta-glycerophosphate, and dexamethasone.

Related Experiment Videos

  • Runx2/Cbfa1 mRNA and protein levels were assessed using RT-PCR and Western blotting.
  • Bone sialoprotein and alkaline phosphatase expression and activity were measured.

    • Main Results:

    • Runx2/Cbfa1 mRNA and protein levels significantly increased within 3 days of culture.
    • Bone sialoprotein expression showed a rapid increase at 3 days and further elevation at 14 days.
    • Alkaline phosphatase expression and activity increased over 7 days, followed by a decline.
    • Collagen mRNA levels remained relatively stable throughout the 14-day culture period.

    Conclusions:

    • Primary human alveolar bone cell cultures demonstrate significant osteogenic potential.
    • Increased Runx2/Cbfa1 expression is a crucial early event in human alveolar osteoblastic differentiation.
    • These findings highlight the importance of Runx2/Cbfa1 in the osteogenic process of human alveolar bone.